Literature DB >> 21795265

Incidence of adult brain cancers is higher in countries where the protozoan parasite Toxoplasma gondii is common.

Frédéric Thomas1, Kevin D Lafferty, Jacques Brodeur, Eric Elguero, Michel Gauthier-Clerc, Dorothée Missé.   

Abstract

We explored associations between the common protozoan parasite Toxoplasma gondii and brain cancers in human populations. We predicted that T. gondii could increase the risk of brain cancer because it is a long-lived parasite that encysts in the brain, where it provokes inflammation and inhibits apoptosis. We used a medical geography approach based on the national incidence of brain cancers and seroprevalence of T. gondii. We corrected reports of incidence for national gross domestic product because wealth probably increases the ability to detect cancer. We also included gender, cell phone use and latitude as variables in our initial models. Prevalence of T. gondii explained 19 per cent of the residual variance in brain cancer incidence after controlling for the positive effects of gross domestic product and latitude among nations. Infection with T. gondii was associated with a 1.8-fold increase in the risk of brain cancers across the range of T. gondii prevalence in our dataset (4-67%). These results, though correlational, suggest that T. gondii should be investigated further as a possible oncogenic pathogen of humans.

Entities:  

Mesh:

Year:  2011        PMID: 21795265      PMCID: PMC3259962          DOI: 10.1098/rsbl.2011.0588

Source DB:  PubMed          Journal:  Biol Lett        ISSN: 1744-9561            Impact factor:   3.703


  25 in total

1.  Missing data: our view of the state of the art.

Authors:  Joseph L Schafer; John W Graham
Journal:  Psychol Methods       Date:  2002-06

Review 2.  Ecological bias, confounding, and effect modification.

Authors:  S Greenland; H Morgenstern
Journal:  Int J Epidemiol       Date:  1989-03       Impact factor: 7.196

3.  Uses of ecologic analysis in epidemiologic research.

Authors:  H Morgenstern
Journal:  Am J Public Health       Date:  1982-12       Impact factor: 9.308

4.  Relationship of central nervous system neoplasms to Toxoplasma gondii infection.

Authors:  L M Schuman; N W Choi; W H Gullen
Journal:  Am J Public Health Nations Health       Date:  1967-05

Review 5.  Inflammation, carcinogenesis and cancer.

Authors:  F A Fitzpatrick
Journal:  Int Immunopharmacol       Date:  2001-09       Impact factor: 4.932

6.  Herpes simplex virus type 2 and cancer: a medical geography approach.

Authors:  Frédéric Thomas; Eric Elguero; Jacques Brodeur; Jerome Le Goff; Dorothée Missé
Journal:  Infect Genet Evol       Date:  2011-04-15       Impact factor: 3.342

Review 7.  Toxoplasmosis.

Authors:  J G Montoya; O Liesenfeld
Journal:  Lancet       Date:  2004-06-12       Impact factor: 79.321

8.  Tumours of the brain and presence of antibodies to Toxoplasma gondii.

Authors:  P Ryan; S F Hurley; A M Johnson; M Salzberg; M W Lee; J B North; J J McNeil; A J McMichael
Journal:  Int J Epidemiol       Date:  1993-06       Impact factor: 7.196

9.  Increasing incidence of primary malignant brain tumors: influence of diagnostic methods.

Authors:  M Desmeules; T Mikkelsen; Y Mao
Journal:  J Natl Cancer Inst       Date:  1992-03-18       Impact factor: 13.506

Review 10.  Epidemiology of primary brain tumors: current concepts and review of the literature.

Authors:  Margaret Wrensch; Yuriko Minn; Terri Chew; Melissa Bondy; Mitchel S Berger
Journal:  Neuro Oncol       Date:  2002-10       Impact factor: 12.300

View more
  38 in total

1.  Can we understand modern humans without considering pathogens?

Authors:  Frédéric Thomas; Simon P Daoust; Michel Raymond
Journal:  Evol Appl       Date:  2012-01-09       Impact factor: 5.183

2.  Determination of a Key Antigen for Immunological Intervention To Target the Latent Stage of Toxoplasma gondii.

Authors:  Qila Sa; Eri Ochiai; Ashish Tiwari; Jeremi Mullins; Nilabh Shastri; Corinne Mercier; Marie-France Cesbron-Delauw; Yasuhiro Suzuki
Journal:  J Immunol       Date:  2017-04-26       Impact factor: 5.422

Review 3.  The immune system utilizes two distinct effector mechanisms of T cells depending on two different life cycle stages of a single pathogen, Toxoplasma gondii, to control its cerebral infection.

Authors:  Yasuhiro Suzuki
Journal:  Parasitol Int       Date:  2019-11-25       Impact factor: 2.230

4.  Culiseta annulata - just a biting nuisance or a deadly foe?

Authors:  Martin Ward; Giovanni Benelli
Journal:  Pathog Glob Health       Date:  2017-11-20       Impact factor: 2.894

5.  CD8(+) T cells remove cysts of Toxoplasma gondii from the brain mostly by recognizing epitopes commonly expressed by or cross-reactive between type II and type III strains of the parasite.

Authors:  Eri Ochiai; Qila Sa; Sara Perkins; Michael E Grigg; Yasuhiro Suzuki
Journal:  Microbes Infect       Date:  2016-04-12       Impact factor: 2.700

Review 6.  Host Organelle Hijackers: a similar modus operandi for Toxoplasma gondii and Chlamydia trachomatis: co-infection model as a tool to investigate pathogenesis.

Authors:  Julia D Romano; Isabelle Coppens
Journal:  Pathog Dis       Date:  2013-07-22       Impact factor: 3.166

Review 7.  Infection and cancer in multicellular organisms.

Authors:  Paul W Ewald; Holly A Swain Ewald
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-19       Impact factor: 6.237

8.  Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour?

Authors:  Joanne P Webster; Maya Kaushik; Greg C Bristow; Glenn A McConkey
Journal:  J Exp Biol       Date:  2013-01-01       Impact factor: 3.312

9.  Seroprevalence and molecular evaluation of toxoplasmosis in children with cancer in Khuzestan province, Southwest of Iran.

Authors:  Jasem Saki; Sanaz Tavakoli; Mohammad Pedram
Journal:  J Parasit Dis       Date:  2017-04-10

10.  The relationship between owning a cat and the risk of developing a brain cancer in a prospective study of UK women: comment on Thomas et al.

Authors:  V S Benson; J Green; V Beral
Journal:  Biol Lett       Date:  2012-08-22       Impact factor: 3.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.